Skip to main content
SpringerLink
Log in

Idiopathischer Morbus Parkinson und antidepressive Therapie - ein Überblick

  • Conference paper
Morbus Parkinson

  • 131 Accesses

Zusammenfassung

Die Einordnung, Einchätzung und Behandlung depressiver Zustandsbilder bei Vorliegen der Grunderkrankung eines idiopathischen Morbus Parkinson hat in den letzten Jahren einen deutlichen Wandel erfahren.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Andersen J, Aabro E, Gulmann N, Hjelmsted A, Pedersen HE (1980) Antidepressive treatment in Parkinson’s disease. A controlled trial of the effect of nortryptyline in patients with Parkinson’s disease treated with L-Dopa. Acta Neurol Scand 62: 210–219

    Article  PubMed  CAS  Google Scholar 

  2. Bader J-P, Hell D (1998) Parkinson-Syndrom und Depression. Fortschr Neurol Psychiatr 66: 303–312

    Article  PubMed  CAS  Google Scholar 

  3. Bayas A, Kornhuber J, Naumann M (2001) Atypische Neuroleptika und neue Antidepressiva in der Therapie neurologischer Erkrankungen. Akt Neurol 28: 62–73

    Article  Google Scholar 

  4. Bunting LK, Fitzsimmons B (1991) Depression in Parkinson’s disease. J Neurosci Nurs 23: 158–164

    Article  PubMed  CAS  Google Scholar 

  5. Caley CF, Friedman JH (1992) Does fluoxetine exacerbate Parkinson’s disease? J Clin Psychiatry 53: 278–282

    PubMed  CAS  Google Scholar 

  6. Ceravolo R, Nuti A, Piccinni A, Dell’Agnello G, Bellini G, Gambaccini G, Dell’Osso L, Murri L, Bonuccelli U (2000) Paroxetine in Parkinson’s disease: effects on motor and depressive symptoms. Neurology 55: 1216–1218

    Article  PubMed  CAS  Google Scholar 

  7. Corrigan MH, Denahan AQ, Wright CE, Ragual RJ, Evans DL (2000) Comparison of pramipexole, fluoxetine, and placebo in patients with major depression. Depress Anxiety 11: 58–65

    Article  PubMed  CAS  Google Scholar 

  8. Cummings JL (1992) Depression and Parkinson’s disease: a review. Am J Psychiatry 149: 443–454

    PubMed  CAS  Google Scholar 

  9. Damier P (1999) The role of dopamine, serotonin, and noradrenaline in Parkinson’s disease. In: Wolters Ech, Scheltens PH, Berendse HW (eds) Mental Dysfunction in Parkinson’s Disease II. Academic Pharmaceutical Productions, Utrecht, pp 254–262

    Google Scholar 

  10. Dell’Agnello G, Ceravolo R, Nuti A, Bellini G, Piccini A, D’Avino C, Dell’Osso L, Bonucelli U (2001) SSRIs do not worsen Parkinson’s disease: evidence from an open-label, prospective study. Clinical Neuropharmacology 24: 221–227

    Article  PubMed  Google Scholar 

  11. Felber W (2001) Depression und Angst beim Parkinson-Syndrom. Akt Neurol 28, Sonderheft 3: 231–234

    Google Scholar 

  12. Hauser RA, Zesiewiscz TA (1997) Sertaline treatment of depression in Parkinson’s disease. Mov Disord 12: 756–759

    Article  PubMed  CAS  Google Scholar 

  13. Hornykiewicz O (1982) Imbalance of brain monoamines and clinical disorders. Prog Brain Res 55: 419–429

    Article  PubMed  CAS  Google Scholar 

  14. Klaassen T, Verhey FRJ, Snejders G (1995) Treatment of depression in Parkinson’s disease: a meta-analysis. J Neuropsychiatry Clin Neurosci 7: 281–286

    PubMed  CAS  Google Scholar 

  15. Laitinen L (1969) Desipramine in treatment of Parkinson’s disease. A placebo-controlled study. Acta Neurol Scand 45: 109–113

    Article  PubMed  CAS  Google Scholar 

  16. Leentjens A, Verhey F, Luijckx G-J, Troost J (2000) The validity of the Beck Depression Inventory as a screening and diagnostic instrument for depression in patients with Parkinson’s disease. Movement Disorder 15 (6): 11221–1224

    Article  Google Scholar 

  17. Mann JJ, Aarons SF, Wilner PJ, Keilp JG, Sweeney JA, Pearlstein T, Frances AJ, Kocsics JH, Brown RP (1989) A controlled study of the antidepressant efficacy and side effects of (-)-deprenyl. A selective monoamine oxidase inhibitor. Arch Gen Psychiatry 46: 45–50

    Article  PubMed  CAS  Google Scholar 

  18. Marsh GG, Markham CH (1973) Does levodopa alter depression and psychopathology in parkinsonism patients? J Neurol Neurosurg Psychiatry 36: 925–935

    Article  PubMed  CAS  Google Scholar 

  19. Mayeux R (1990) Depression in the patient with Parkinson’s disease. J Clin Psychiatry 51 (Suppl): 20–23

    PubMed  Google Scholar 

  20. Poewe W, Koller WC (2000) Evidence-based medicine review of PD treaments: the MDS project. Mov Disord 15, Suppl 3: 6

    Google Scholar 

  21. Poewe W, Seppi K (2001) Treatment options for depression and psychosis in Parkinson’s disease. J Neurol 248, Suppl 3: III/12-III/21

    Article  Google Scholar 

  22. Rascol O et al. (2002) Treatment interventions for Parkinson’s disease: an evidence based assessment. Lancet 359: 1589–1598

    Article  PubMed  Google Scholar 

  23. Richard IH, Kurlan R, and the Parkinson Study group (1997) A survey of antidepressant drug use in Parkinson’s disease. Neurology 34: 642–646

    Google Scholar 

  24. Sano M, Stern Y, Williams J, Cote L, Rosenstein R, Mayeux R (1989) Coexisting dementia and depression in Parkinson’s disease. Arch Neurol 46: 1284–1286

    Article  PubMed  CAS  Google Scholar 

  25. Slaughter JR, Slaughter KA, Nichols D, Holmes S, Matrens MP (2001) Prevalence, Clinical manifestations, Etiology, and Treatment of depression in Parkinson’s Disease. J Neuropsychiatry Clin Neurosci 13 (2): 187–196

    Article  PubMed  CAS  Google Scholar 

  26. Starkstein SE, Preziosi TJ, Bolduc PL et al. (1990) Depression in Parkinson’s Disease. J Nery Ment Dis 178: 27–31

    Article  CAS  Google Scholar 

  27. Steur EN (1993) Increase of Parkinson disability after fluoxetine medication. Neurology 43: 211–213

    Article  PubMed  CAS  Google Scholar 

  28. Steur EN, Ballering LA (1997) Moclobemide and selegeline in the treatment of depression in Parkinson’s disease. J Neurol Neurosurg Psychiatry 63: 457

    Article  Google Scholar 

  29. Strang RR (1965) Imipramine in treatment of Parkinson’s disease: a double-blind placebo study. BMJ 2: 33–34

    Article  PubMed  CAS  Google Scholar 

  30. Tandberg E, Larsen JP, Aarsland D, Cummings JL (1996) The occurrence of depression in Parkinson’s disease. A community-based study. Arch Neurol 53: 175–179

    Article  PubMed  CAS  Google Scholar 

  31. Tom T, Cummings JL (1998) Depression in Parkinson’s disease. Pharmacological characteristics and treatment. Drugs Aging 12: 55–74

    Article  PubMed  CAS  Google Scholar 

  32. Yamamoto M (2001) Depression in Parkinson’s disease: its prevalence, diagnosis and neurochemical background. J Neurol 248, Suppl 3: III/5-III/11

    Google Scholar 

Download references

Authors
  1. M. Gastpar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Meiering
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Neurologische Klinik der Ruhr-Universität Bochum St. Josef-Hospital, Gudrunstraße 56, 44791, Bochum, Germany

    Horst Przuntek  & Thomas Müller  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Gastpar, M., Meiering, C. (2003). Idiopathischer Morbus Parkinson und antidepressive Therapie - ein Überblick. In: Przuntek, H., Müller, T. (eds) Morbus Parkinson. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57362-0_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-57362-0_7

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-7985-1422-5

  • Online ISBN: 978-3-642-57362-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation